Skip to content

S. 1497 · 118th Congress (2023–2025)

Emergency Access to Insulin Act of 2023

This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin.

Specifically, the bill requires the Department of Health and Human Services (HHS) to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual’s health plan deductible or other out-of-pocket expenses required under the plan. Further, HHS must collect annual fees from insulin manufacturers, based on each manufacturer’s market share, equal to the total estimated expenditures under the insulin grants program.

Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.

Show official title

A bill to amend the Public Health Service Act to establish insulin assistance programs, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 1497’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Tina Smith (D-MN)
Policy area
Health
Subjects
  • Accounting and auditing
  • Business ethics
  • Business records
  • Competition and antitrust
  • Congressional oversight
  • Digestive and metabolic diseases
  • Government information and archives
  • Health care costs and insurance
  • 18 more
    • Health care coverage and access
    • Health information and medical records
    • Health programs administration and funding
    • Health technology, devices, supplies
    • Indian social and development programs
    • Inflation and prices
    • Intergovernmental relations
    • Licensing and registrations
    • Manufacturing
    • Minority health
    • Performance measurement
    • Prescription drugs
    • Public contracts and procurement
    • Public-private cooperation
    • Retail and wholesale trades
    • Sales and excise taxes
    • State and local finance
    • State and local government operations

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources
  3. Expired

    Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.

Committees

  1. SenateFinanceReferred May 9, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Emergency Access to Insulin Act of 2023

    Display title, Short title · Introduced in Senate

  2. A bill to amend the Public Health Service Act to establish insulin assistance programs, and for other purposes.

    Official title · Introduced in Senate